Brain Tumor News!


Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 1950 to 1969 of 7,806
Previous 20           Next 20


11/17/15 Drug That Could Limit Spread of Deadly Brain Tumours        

 This should be tested in combination with Avastin. Might make a big impact!



11/17/15 Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data        

Amazing number of presentations for Optune. So glad to see the brain tumor community finally embracing this new treatment option!



11/07/15 Toca5: A Phase 2/3 Randomized, Open Label Study of Toca 511™, a Retroviral Replicating Vector, Combined With Toca FC™ versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma        

 The Tocagen trial has just opened!  Our website and clinicaltrials.gov do not have the details yet, but if you are interested in this trial, call them and ask where it is being done.  This is for people with recurrent GBM or Anaplastic Astrocytoma, who are going to have surgery.  There is a video on how this works at http://www.tocagen.com/toca5/

 This is one of my favorite new trials.  (Disclaimer: Tocagen is a sponsor of the Musella Foundation)



11/07/15 Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.        

 This is just theoretical, but it makes sense to me. Might be worth trying to add Dapsone if you are on Erlotinib.  At the least it will help the rash, and at best might kill the tumor better!



11/06/15 Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor        

 This is only in 1 patient so far but may lead to a major breakthrough in the treatment of this tumor type since they reported that nearly all patients with this tumor type have the mutation this drug targets.



11/04/15 No Impact With Mifepristone in Patients With Meningioma        

 This is a small study, but the patients in the placebo group did better than those who took Mifepristone for meningiomas.



10/30/15 Swedish Medical Center in Seattle announces a clinical trial in humans for the treatment of glioblastoma        

 This is a very exciting trial.  It is now open and will show up on our website and clinicaltrials.gov in a few days but you can contact them directly if you are interested. It is for newly diagnosed gbm patients only.



10/30/15 Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.        

 This has an interesting result: Using Temozolomide right after surgery compared to waiting until radiation starts resulted in a big increase in median overall survival, but a decrease in progression free survival.  It makes a lot of sense to me to start the Temozolomide right away (although we have to study the effect on wound healing), but more research is needed to see why the progression free survival goes down while the overall survival goes up. 



10/30/15 IBTA News        

 From our good friends at the IBTA



10/14/15 Cancer drug’s effectiveness overinflated in animal studies        

 This is a major problem. All research should be reported - even negative results. Negative results are just as important, as they can prevent people from using the drug and prevent other researchers from trying the same experiments over and over again wasting time and money



10/14/15 Dr. Jim Olson: How to defeat cancer, with help from nature, scorpions and innovative thinking        

 Important video - talks about a new approach to finding treatments for brain tumors as well as other diseases



10/14/15 Santosh Kesari, M.D., Ph.D., F.A.N.A, F.A.A.N., has joined the Pacific Brain Tumor Center and the John Wayne Cancer Institute at Providence Saint John’s Health Center in Santa Monica,        

 Dr Kesari is a friend of mine, and a great brain tumor doctor and researcher!  Just wanted to let you know he moved.



10/13/15 Video Games Can Improve Cancer Survivors’ Cognitive Abilities        

Glad to hear this.  They researched a particular program which requires health coaches. I would like to see research on playing free or inexpensive games that kids love, such as candy crush and Mahjong to se if it can help.



10/11/15 New book about a husband and wife who both had brain tumors is raising money for brain tumor research!        

 Steve has very graciously donated the proceeds of the first 6 months' sale of his book to the Musella Foundation!



10/11/15 Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.        

 This is only in the test tube and in mice, so more research is needed. This is a perfect use of the brain tumor virtual trial... we have 7 patients who used Metformin in addition to Temodar, and they seem to be doing better than average. That is not enough patients to even consider using it but it is a good start. If everyone reading this joined the virtual trial project, we would have enough data to say it is worth using - or not.  Go to virtualtrials.com and click virtual trial to join and for details. It is free and easy - we do not tell you what to do - we just observe the outcome.



10/08/15 A new way to donate without it costing you a penny!        

I need your help with this new fundraiser:  we are asking that you donate your refund from this class action settlement to the Musella Foundation.  We will use it to fund brain tumor research and to help patients get access to their treatments through our copayment assistance program.

We did similar fundraisers in the past, and the donations add up quickly.  This is simple – takes less than 3 minutes to read and fill out a simple form. No receipts are necessary. You just enter your name, address and answer a few questions and submit the form online. No paperwork unless you like paper – in which case you can fill out the paper version and send it to us!

Please pass this along to your friends and family and ask that they also donate their refund.  Share it on Facebook and Twitter! If you own a business, you can donate your company’s refund.  You can ask your employer if they would consider donating. 

Your donation is tax deductible, and we will send a tax receipt for the amount you generate.



10/08/15 VBI Vaccines Announces Development of a Novel Glioblastoma Immunotherapy Candidate        

 This will target the cytomegalovirus, which some researchers say is associated with 100% of GBMs, so it should make a great target.



10/05/15 FDA Expands Optune's Glioblastoma Multiforme Indication        

 Fantastic news! The FDA acted quickly! They approved Optune for Newly Diagnosed Glioblastoma to be used in addition to the standard treatment!

 It results in "the risk of progression or death was reduced by 37 percent "



10/05/15 Musella Foundation Copayment Assistance program has reopened!        

 We don't have much funding so it may close quickly. If you are interested, get in your paperwork quickly. It is first come first served.



10/05/15 Novocure Announces CE Mark and First Patient Use of Second Generation Optune System        

 The second generation Novocure device is now available in Europe. Hopefully will get FDA approval to use it in the USA soon!   It is half the size and weight of the old system, and looks a lot better!



Displaying Stories 1950 to 1969 of 7806
Previous 20           Next 20